O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
US5665772A · kind A · utility
170Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 7, 1995 |
| Grant date | Sep 9, 1997 |
| Priority date | — |
| Expiry date | Apr 7, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel derivatives of rapamycin, particularly 9-deoxorapamycins, 26-dihydro-rapamycins, and 40-0-substituted and 28,40-0,0-di-substituted rapamycins, are found to have pharmaceutical utility, particularly as an immunosuppressants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.